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Abstract RBCK1 (RBCC protein interacting with PKC 1) has
two coiled-coil regions, a RING finger, a B-box and a B-box-like
motif. RBCK2, a cDNA fragment related to RBCK1 was
obtained, that lacks the 161-bp sequence of RBCK1 and encodes
260 amino acid residues. The 240-amino acid sequence in the
NH2-terminal of RBCK2 is identical with RBCK1 and contains
two coiled-coil regions but no other structural motifs, whereas
the 20-amino acid sequence in the COOH-terminal is distinct
from RBCK1. The analysis of genomic DNA revealed that
RBCK1 and RBCK2 are generated from a single gene by
alternative splicing. The RBCK1 protein interacted with the
RBCK1 and RBCK2 proteins, but the RBCK2 protein did not
interact with itself, in vitro. The RBCK2 protein fused with the
DNA-binding domain of yeast GAL4 (GAL4DBD) did not show
a transcriptional activity, but the RBCK2 protein inhibited the
transcriptional activity of the RBCK1 protein fused with
GAL4DBD. These results suggest that RBCK2 may inhibit the
transcriptional activity of RBCK1 probably through complex
formation with RBCK1.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The RBCC (RING, B-Box, Coiled-coil) protein family
shares a common molecular organization, NH2-(RING ¢n-
ger)-(B-box)-(Coiled-coil)-COOH [1], and about 10 proteins
including efp [2], PML [3], T18 [4], rfp [5] and XNF-7 [6],
have been identi¢ed as the family proteins. The precise phys-
iological role of these RBCC proteins has not been elucidated,
however, it is presumed that RING-zinc ¢nger [7], B-box zinc-
binding domain [8] and coiled-coil region [9] mediate protein-
protein interactions. By the yeast two-hybrid screening using
the regulatory domain of protein kinase C LI as a bait, a
novel protein kinase C-interacting protein was identi¢ed
from a rat brain cDNA library [10]. Interestingly, the protein
contains structural motifs such as two coiled-coil regions, a
RING ¢nger, a B-box and a B-box-like motif in the order
from NH2- to COOH-terminals. As the protein has a unique
molecular organization similar to the RBCC protein family,
the protein was designated RBCK1 (RBCC protein interact-
ing with PKC 1). By fusion with the DNA-binding domain of
a yeast transcription factor GAL4 (GAL4DBD), the RBCK1
protein was found to possess a transcriptional activity in
mammalian cells. Recently, XAP3 (a human hepatitis B virus
X protein-associated protein) was cloned, that enhances the
transactivation of gene expression by the hepatitis B virus X
protein [11]. The XAP3 protein shows more than 90% simi-
larity to the RBCK1 protein; however, the NH2-terminal end
sequence of XAP3 is distinct from RBCK1. Comparison of
the nucleotide sequences indicated that RBCK1 has an addi-
tional region which is absent in XAP3, and that the 5P-non-
coding region of RBCK1 encodes a peptide sequence highly
similar to the NH2-terminal end region of XAP3. Therefore, it
is suggested that RBCK1 and XAP3 are the splicing variants
produced from a homologous gene of di¡erent mammalian
species, that may have a role in transcriptional control. While
the RBCK1 cDNA fragment was ampli¢ed by PCR from a
rat cDNA library, a fragment smaller than RBCK1 was iso-
lated. The cDNA fragment encodes a splicing variant of
RBCK1, which is distinct from XAP3. In this study, we report
molecular cloning and characterization of RBCK2, a novel
splicing variant of RBCK1.
2. Materials and methods
2.1. DNA cloning
Two cDNA fragments of approximately 1.6 and 1.8 kbp were am-
pli¢ed from a rat brain cDNA library for yeast two-hybrid screening
(pGAD10-based; Clontech) by two steps of PCR using the primers
corresponding to the RBCK1 DNA sequence. The primers for the
primary PCR are 5P-aagaccaagaaagcagaggag-3P (sense, nucleotides
305^325 of RBCK1) and 5P-aacagatgcggctgtgggtcc-3P (antisense, nu-
cleotides 2160^2180 of RBCK1). The primers for the nested PCR are
5P-atggccctgagccttgcccgg-3P (sense, nucleotides 326^346 of RBCK1)
and 5P-ctcagggagcaagctgagggg-3P (antisense, nucleotides 2140^2160
of RBCK1). Genomic DNA fragments were cloned by two steps of
PCR from an adapter-ligated rat genomic DNA (Rat GenomeWalker
Kit; Clontech). The primers used are as follows: AP1 primer (adapt-
er-derived upstream, Clontech); AP2 primer (adapter-derived down-
stream, Clontech); L15-IN1, 5P-atccctgcctcgtaccagcctgatg-3P (sense,
nucleotides 965^989 of RBCK1); L15-IN2, 5P-taccagcctgatgaggag-
gagcgag-3P (sense, nucleotides 977^1001 of RBCK1); L15-IC1, 5P-
ccagggcatgagtaggtgttgtcaatg-3P (antisense, nucleotides 1264^1290 of
RBCK1); L15-IC2, 5P-tgtcaatgaaggggcaggatacctc-3P (antisense, nu-
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cleotides 1247^1271 of RBCK1). The ¢rst PCR was performed with
AP1 primer and L15-IN1, or AP1 primer and L15-IC1 primer, and the
second PCR was performed using AP2 primer and L15-IN2, or AP2
primer and L15-IC2 primer. The ampli¢ed DNA fragments were li-
gated to pCR2.1 vector (Invitrogen), and sequenced on both strands
by using a DNA sequencer model 373S (Applied Biosystems). Predic-
tion of coiled-coil regions [9] was carried out at the Swiss Institute for
Experimental Cancer Research WWW site (http://ulrec3.unil.ch/soft-
ware/COIL-form.html).
2.2. Detection of mRNA
Northern blot analysis was carried out by hybridizing the RNA
blot containing approximately 2 Wg of mRNAs from adult rat tissues
(Clontech) with the 32P-labeled DNA fragment of either a common
sequence of RBCK1 and RBCK2 (nucleotides 326^486 of RBCK1) or
a RBCK1-speci¢c sequence (nucleotides 1042^1202 of RBCK1) under
the conditions described [12]. The radioactivity in hybridized bands
was analyzed by a Bio-Imaging Analyzer BAS2000 (Fuji). RT-PCR
was carried out employing the ¢rst-strand cDNAs synthesized from
poly(A) RNAs puri¢ed from normal rat tissues by using QuickPrep
mRNA Puri¢cation Kit and Ready-To-Go T-primed First-Strand Kit
(Pharmacia). The primers for the primary PCR are 5P-tatggctttccacc-
cagcctg-3P (sense, nucleotides 569^589 of RBCK1) and 5P-tcgattctctgc-
gatggacac-3P (antisense, nucleotides 1361^1381 of RBCK1). The prim-
ers for the nested PCR are 5P-ggaggcgctgcgccagtatga-3P (sense,
nucleotides 1021^1041 of RBCK1) and 5P-caggaaacgctggtagtcctc-3P
(antisense, nucleotides 1311^1331 of RBCK1). PCR was carried out
for 20 cycles of denaturing at 94‡C for 30 s, annealing at 55‡C 1 min
and elongation at 68‡C for 90 s. A series of the mixture of RBCK1
and RBCK2 (RBCK1 cDNA/RBCK2 cDNA = 10 ng/10 pg, 1 ng/10
pg, 100 pg/10 pg, 10 pg/10 pg, 10 pg/100 pg) was used as control.
2.3. Expression plasmids
The full-length sequences of RBCK1 and RBCK2 were inserted
into a pTB701-FLAG vector [12] to construct the expression vectors
containing a FLAG-epitope tag at the NH2-terminal end, and desig-
nated RBCK1-FLAG and RBCK2-FLAG, respectively. The fusion
protein constructs of RBCK1 and RBCK2 containing GST at the
NH2-terminal end were made by using pGEX-4T-1 vector (Pharma-
cia), and designated GST-RBCK1 and GST-RBCK2, respectively.
The full-length sequences of RBCK1 and RBCK2 were inserted into
pM vector (Clontech) to construct the expression vectors of RBCK1
and RBCK2 proteins fused with GAL4DBD at the NH2-terminal
end, and designated RBCK1-GAL4DBD and RBCK2-GAL4DBD,
respectively. pFA-CREB plasmid (Stratagene) was used for expression
of CREB protein fused with GAL4DBD at the NH2-terminal end
(CREB-GAL4DBD).
2.4. In vitro binding assay
The lysate of E. coli DH5K expressing either GST-RBCK1 or GST-
RBCK2 was applied onto a glutathione-Sepharose 4B column (Phar-
macia), and the GST-fusion protein was eluted according to the man-
ufacturer’s protocol [10]. The eluate was subjected onto Mono Q
column (HR 5/5, Pharmacia), and the proteins were eluted by a linear
concentration gradient of NaCl (0^0.5 M) in the bu¡er (20 mM Tris-
HCl at pH 7.5, 1 mM EDTA, 1 mM EGTA, 10 mM 2-mercapto-
ethanol, 0.3 mM PMSF). COS-7 cells (about 5U107 cells) expressing
either RBCK1-FLAG or RBCK2-FLAG were suspended in 500 Wl of
lysis bu¡er (20 mM Tris-HCl at pH 7.5, 300 mM NaCl, 1 mM EDTA,
1 mM EGTA, 10 mM 2-mercaptoethanol, 10 mM NaF, 1 mM
Na3VO4, 1 mM PMSF, 1 tablet/50 ml complete protease inhibitor
cocktail tablet (Boehringer Mannheim), 1% (v/v) Triton X-100).
Cleared lysate was incubated with puri¢ed GST-RBCK1 or GST-
RBCK2 (approximately 10 Wg) immobilized onto 20 Wl (50% slurry)
of glutathione-Sepharose 4B beads. After incubation at 4‡C for 1 h,
the beads were washed four times with the lysis bu¡er containing 0.1%
(v/v) Triton X-100, and subjected to 12.5% SDS-polyacrylamide gel
electrophoresis. Western blot analysis was carried out using an anti-
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Fig. 1. Structure and genomic sequence of RBCK1 and RBCK2. A: Schematic drawing of RBCK1 and RBCK2. The amino acid residue num-
bers of the beginning and end of the proteins and the motifs are indicated on the top. The dotted lines indicate the correspondence of the nu-
cleotide sequences. B: Partial genomic sequence encoding the divergent regions of RBCK1 and RBCK2. The sequence corresponding to the
cDNA sequence of RBCK1 is boxed and indicated as exons A, B and C. The intron sequences between exons A and exon B (982 bp) and
exons B and C (1013 bp) are abbreviated. Consensus sequences for 5P- and 3P-splice sites are underlined. Nucleotides of the intervening sequen-
ces are numbered on the right.
C. Tokunaga et al./FEBS Letters 435 (1998) 11^1512
FLAG monoclonal antibody (M2, Eastman Kodak) as a primary
antibody, and an alkaline phosphatase-conjugated anti-mouse
IgG(H+L) antibody (Promega) as a secondary antibody [13].
2.5. Transcriptional activity
COS-7 cells (about 2.5U105 cells) were transfected with each tran-
scription factor plasmid (50 ng; pM (GAL4DBD), RBCK1-
GAL4DBD, RBCK2-GAL4DBD or CREB-GAL4DBD) and the re-
porter plasmid pFR-LUC (1 Wg, Stratagene) which contains the luci-
ferase gene from the ¢re£y Photinus pyralis downstream of the syn-
thetic promoter containing ¢ve copies of the 17-mer GAL4-
recognition site. Where indicated, the RBCK2-expression plasmid
(0^750 ng; RBCK2-FLAG) was co-transfected. After incubation for
24 h cells were washed once with phosphate-bu¡ered saline and lysed
with 200 Wl of Passive Lysis Bu¡er (Promega). Each cell lysate (10 Wl)
was transferred into the tube containing 50 Wl of the luciferase sub-
strate solution (Promega). The luminescence originated from the ¢re-
£y luciferase was measured as relative light units (RLU) by a lumi-
nometer (Lumat LB9507, EGpG Berthold). The transcriptional
activity was de¢ned as RLU/protein content of the sample.
3. Results and discussion
When the RBCK1 cDNA fragment of about 1.8 kbp encod-
ing the full length of the RBCK1 protein (Met-1 to His-498)
[10] was ampli¢ed by PCR from a rat brain cDNA library, an
additional cDNA fragment of about 1.6 kbp was ampli¢ed
simultaneously. The smaller cDNA fragment lacked the 161-
bp sequence corresponding to nucleotides 1046^1206 of
RBCK1 (accession number U48248), while the rest of the
nucleotide sequence of these two cDNA fragments was iden-
tical. The smaller cDNA fragment has an open reading frame
encoding a polypeptide of 260 amino acid residues consisting
of the 240 amino acid residues (Met-1 to Gln-240) sharing
with the RBCK1 protein and a divergent sequence of 20 ami-
no acids followed by a stop codon (accession number
AB011369). The smaller cDNA fragment designated RBCK2
encodes a protein with a calculated molecular weight of
29 086, which has two coiled-coil regions (amino acid residues
131^150, 221^243) but no zinc ¢ngers such as RING ¢nger
and B-box (Fig. 1A). We isolated independent cDNA clones
encoding RBCK2 from the rat brain cDNA library. The ge-
nomic DNA fragments encoding RBCK1 were isolated, and
the DNA sequence encoding amino acid residues Tyr-218^
Val-309 of the RBCK1 protein (nucleotides 978^1250 of the
RBCK1 cDNA) was determined that involves the RBCK1-
speci¢c sequence of 161 bp (Fig. 1B, exon B). It was shown
that the cDNA sequence of RBCK1 surrounding the 161-bp
sequence was divided into three regions in the genomic DNA,
and both 5P- and 3P-terminal end sequences of the two inter-
vening regions completely ¢t with the consensus sequences of
donor/acceptor splicing sites [14]; introns begin with GT and
end with AG. No open reading frame having more than 50
amino acid residues was found in these intervening regions.
These results indicate that these two intervening regions are
introns and the RBCK1-speci¢c sequence of 161 bp is an
independent exon, and that RBCK1 and RBCK2 are tran-
scribed from a single gene by alternative ways of splicing.
Northern blot analysis of rat tissues was carried out by
using a probe common for RBCK1 and RBCK2 and a probe
speci¢c to RBCK1. An RNA transcript of about 2.4 kilonu-
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Fig. 2. Northern blot and RT-PCR of RBCK1 and RBCK2. A: Northern blot of RBCK1 and RBCK2 in normal rat tissues. Positions of size
markers in kilonucleotides (knt) are shown on the left. The mutual sequence of RBCK1 and RBCK2 (left panel) and the insert sequence of
RBCK1 (middle panel) are used as the common and RBCK1-speci¢c probes, respectively. Rat L-actin is used as a control (right panel). B:
RT-PCR analysis of RBCK1 and RBCK2 mRNA in rat tissues. cDNA of RBCK1, RBCK2 and a series of the mixture of RBCK1 and
RBCK2 as indicated and RNA from rat tissues were used as template.
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cleotides (knt) was detected by both probes in all tissues ex-
amined (Fig. 2A). The expression of the 2.4-knt RNA tran-
script was low in brain, but the band was detected after longer
exposure (data not shown). The expression of the RBCK1 and
RBCK2 mRNA was investigated by RT-PCR (Fig. 2B).
When PCR was carried out using a mixture of RBCK1 and
RBCK2 cDNAs, RBCK2 was not ampli¢ed e⁄ciently when
RBCK1 existed, probably because RBCK1 prevents the am-
pli¢cation of RBCK2. The 150-bp fragment of RBCK2 was
still observed in addition to the 311-bp fragment derived from
RBCK1 in all rat tissues examined. In addition, both the
RBCK1 cDNA and the RBCK2 cDNA were obtained as in-
dependent clones from a rat brain cDNA library (data not
shown). The human XAP3 protein [11] is highly homologous
to the RBCK1 protein. The 12-amino acid sequence of the
NH2-terminal end region of XAP3 protein is completely dif-
ferent from the corresponding region of the RBCK1 protein;
however, the 5P-non-coding region of the RBCK1 cDNA (nu-
cleotides 196^315) encodes a peptide highly similar to the
NH2-terminal region of the XAP3 protein. It seems that the
RBCK1 protein and the XAP3 protein are splicing variants
having distinct amino acid sequences in the NH2-terminal end
region. Therefore, at least three splicing variants, such as
RBCK1, RBCK2 and XAP3 seem to be generated from a
single gene. The 2.4-knt transcript in Fig. 2A may contain
these RNA transcripts. It is worth noting that RBCK2 has
another open reading frame starting from nucleotide 570, that
encodes the 363-amino acid sequence having B-box and B-
box-like motif but no coiled-coil region or RING ¢nger. Fur-
ther studies are required for the identi¢cation of the splicing
variants derived from the RBCK1 gene.
The RBCK1 and RBCK2 proteins contain two coiled-coil
regions, which are regarded to mediate the protein-protein
interactions by forming amphipathic K-helix structures and
are found in the dimerization elements of the transcription
factors [9]. Thus, the interaction of RBCK1 and RBCK2 pro-
teins was investigated. The lysate of COS-7 cells expressing
either FLAG epitope-tagged RBCK1 or RBCK2 was mixed
with the GST-RBCK1 or GST-RBCK2 protein, and Western
blot analysis using the anti-FLAG antibody showed that
GST-RBCK1 protein associated with both RBCK1-FLAG
and RBCK2-FLAG proteins, and that the GST-RBCK2 pro-
tein associated with the RBCK1-FLAG protein, but not with
the RBCK2-FLAG protein (Fig. 3). Association between the
GST-RBCK2 protein and the RBCK2-FLAG protein was not
observed, even when twice the amounts of the GST-RBCK2
protein were employed (data not shown). As the coiled-coil
regions alone could not mediate homo-dimerization of the
RBCK2 protein, the COOH-terminal half of the RBCK1 pro-
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Fig. 4. Inhibition of transcriptional activity of RBCK1 by RBCK2. A: Transcriptional activity of RBCK1 and RBCK2. RBCK1-GAL4DBD
and RBCK2-GAL4DBD were expressed and the transcriptional activities were measured. The data are shown as a ratio to the mean value of
the activity in the control cells transfected with pFR-LUC and pM (GAL4 DBD). B: E¡ect of the expression of RBCK2 on the transcriptional
activity of RBCK1 and CREB. RBCK1-GAL4DBD or CREB-GAL4DBD was expressed with RBCK2 and the transcriptional activity was
measured. The transcriptional activity was calculated as a percentage of the mean value of the activity in the cells transfected with pFR-LUC
and RBCK1-GAL4DBD or CREB-GAL4DBD. These results were of three independent experiments, each in duplicate, and the mean values
with error bars (P6 0.05) are indicated.
Fig. 3. Interaction between RBCK1 and RBCK2 proteins in vitro.
The binding between RBCK1 and RBCK2 proteins was measured
using GST-fusion proteins and FLAG-epitope tagged proteins.
Bound proteins were eluted and analyzed by Western blot analysis
using the anti-FLAG antibody. Positions of molecular weight
markers are shown in the middle. Input lanes contain 5% of the
proteins used in the binding assay.
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tein including a RING ¢nger, a B-box and a B-box-like motif
may be important for the interaction of the RBCK1 protein
and of the RBCK1 and RBCK2 proteins.
We have already reported that the RBCK1 protein has a
transcriptional activity and the COOH-terminal half of the
RBCK1 protein involves the transcription activating domain
[10]. The transcriptional activity of the RBCK2 protein was
examined by using a fusion protein of the RBCK2 protein
and GAL4DBD (RBCK2-GAL4DBD) in COS-7 cells harbor-
ing the reporter plasmid containing the ¢re£y luciferase gene
downstream of the synthetic promoter containing the GAL4-
recognition sequence. As shown in Fig. 4A, the RBCK2-
GAL4DBD protein showed a luciferase activity of similar
level as the control GAL4DBD protein, whereas the
RBCK1-GAL4DBD protein showed about 20-fold higher lu-
ciferase activity than the GAL4DBD protein. When the
RBCK2 expression plasmid was co-transfected with
RBCK1-GAL4DBD, the transcriptional activity of the
RBCK1-GAL4DBD protein was inhibited in a dose-depend-
ent manner of the RBCK2 protein (Fig. 4B). On the other
hand, the transcriptional activity of the GAL4DBD-fused
CREB protein [15] was not a¡ected by the overexpression
of the RBCK2 protein. The RBCK2 protein may interact
with the transcriptional activating domain of the RBCK1
protein, presumably in its COOH half. In several families of
transcription factors, short coiled-coil regions of 2^5 heptads,
such as a leucine zipper [16,17], mediate the homo- and het-
ero-dimerization of the factors. As the RBCK2 protein could
not make a homo-dimer under the conditions employed, it
seems possible that not only the coiled-coil regions but also
other structural motifs such as the RING ¢nger and the B-
box may be involved in the interaction of the RBCK1 and
RBCK2 proteins.
Some transcription factors are generated by alternative
splicing mechanisms. In the case of the CREB family, eight
species of CREB-related mRNAs are produced from a single
gene by alternative splicings [18]. Only two species of them,
CREBK and CREBv, show transcriptional activity, although
the functions of other species have not been elucidated. It has
been reported that an alternative AP-2 transcript (AP-2B)
inhibits the activity of AP-2 transactivator [19]. Namely,
AP-2B inhibits AP-2 transactivation through inhibition of
its sequence-speci¢c DNA binding, even though no direct in-
teraction between AP-2A and AP-2B is observed. Recently, it
has been reported that TRAF2 (tumor necrosis factor recep-
tor-associated factor 2)-mediated NF-UB activation is inhib-
ited by TRAF2A, a splice variant of TRAF2 that has a seven-
amino acid insert within the RING ¢nger domain of TRAF2
[20]. It is, however, still unknown whether TRAF2 and TRA-
F2A associate to inhibit NF-UB activation. In this study, the
RBCK2 protein, a splicing variant of the RBCK1 protein,
was revealed to inhibit the transcriptional activity of the
RBCK1 protein, probably through the complex formation
with the RBCK1 protein.
Recently, we have reported that both the RING ¢nger and
the B-box are indispensable for the transcriptional activity of
RBCK1. However, the physiological role of these motifs of
the RBCK1 protein is not yet clear [21]. The interaction be-
tween the RBCK1 and RBCK2 proteins might have some role
in cellular function. To clarify the physiological roles of these
proteins, it is important to elucidate the target genes and the
associating proteins of the RBCK1 protein as a transcription
factor.
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